Telcare developed the first FDA-cleared cellular enabled blood glucometer and cloud-based diabetes data repository system. This system transmits patient data into a cloud-based analytical engine, which monitors trends for caregivers to review.
“We chose the diabetes market as our first major digital population health initiative because of its significant overall burden on the healthcare system, with estimated direct annual costs in the U.S. of over $245 billion,” said Joseph H. Capper, president and CEO of BioTelemetry.
BioTelemetry acquired Telcare for upfront consideration of $7 million in cash. There is the potential for performance-based earn-outs of up to $5 million in cash.
More articles on health IT:
AHA endorses Teladoc
Philips to advance cancer treatment with New York Medical College collaboration
Henry Ford Hospital leverages 3-D imaging for improved cardiac outcomes
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
